King Luther Capital Management Corp increased its position in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 35.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 45,591 shares of the company's stock after acquiring an additional 11,900 shares during the period. King Luther Capital Management Corp owned approximately 0.25% of Addus HomeCare worth $4,508,000 at the end of the most recent quarter.
A number of other hedge funds have also recently bought and sold shares of ADUS. Alliancebernstein L.P. increased its stake in Addus HomeCare by 0.5% in the 4th quarter. Alliancebernstein L.P. now owns 19,661 shares of the company's stock worth $2,465,000 after purchasing an additional 91 shares in the last quarter. Natixis increased its stake in Addus HomeCare by 111.9% in the 4th quarter. Natixis now owns 250 shares of the company's stock worth $31,000 after purchasing an additional 132 shares in the last quarter. Heritage Family Offices LLP increased its stake in Addus HomeCare by 6.3% in the 1st quarter. Heritage Family Offices LLP now owns 2,417 shares of the company's stock worth $239,000 after purchasing an additional 143 shares in the last quarter. Hohimer Wealth Management LLC increased its stake in Addus HomeCare by 6.3% in the 1st quarter. Hohimer Wealth Management LLC now owns 2,561 shares of the company's stock worth $253,000 after purchasing an additional 152 shares in the last quarter. Finally, Stifel Financial Corp increased its stake in Addus HomeCare by 1.2% in the 4th quarter. Stifel Financial Corp now owns 12,794 shares of the company's stock worth $1,604,000 after purchasing an additional 153 shares in the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of brokerages recently weighed in on ADUS. Macquarie reissued an "outperform" rating and issued a $133.00 price target on shares of Addus HomeCare in a research note on Tuesday, June 10th. Wall Street Zen raised Addus HomeCare from a "hold" rating to a "buy" rating in a research note on Sunday, June 29th. TD Cowen lifted their target price on Addus HomeCare from $135.00 to $139.00 and gave the company a "buy" rating in a research note on Wednesday, August 6th. Finally, JMP Securities reaffirmed a "market outperform" rating and set a $150.00 target price on shares of Addus HomeCare in a research note on Wednesday, July 16th. Seven research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus price target of $142.86.
Check Out Our Latest Report on Addus HomeCare
Addus HomeCare Stock Up 1.1%
NASDAQ:ADUS traded up $1.25 on Friday, hitting $115.11. 179,841 shares of the company's stock traded hands, compared to its average volume of 198,476. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.17. Addus HomeCare Corporation has a 1 year low of $88.96 and a 1 year high of $136.72. The firm has a 50-day moving average price of $111.91 and a 200-day moving average price of $107.44. The company has a market cap of $2.12 billion, a PE ratio of 25.41, a price-to-earnings-growth ratio of 1.73 and a beta of 0.80.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its earnings results on Monday, August 4th. The company reported $1.49 earnings per share for the quarter, beating the consensus estimate of $1.45 by $0.04. The company had revenue of $349.44 million for the quarter, compared to analysts' expectations of $345.71 million. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%. The business's revenue for the quarter was up 21.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.35 EPS. Equities analysts anticipate that Addus HomeCare Corporation will post 4.59 EPS for the current fiscal year.
Insider Activity
In other news, EVP Michael D. Wattenbarger sold 2,045 shares of Addus HomeCare stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total transaction of $235,175.00. Following the completion of the sale, the executive vice president directly owned 7,796 shares in the company, valued at $896,540. The trade was a 20.78% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 4.50% of the stock is currently owned by corporate insiders.
Addus HomeCare Profile
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Further Reading

Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.